FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer

By Team VOH

The U.S. Food and Drug Administration (FDA) has granted approval to the Promega OncoMate

Read more